Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 4419-94-7
2. 4-nitrophenyl Beta-lactoside
3. P-nitrophenylbeta-d-lactopyranoside
4. P-nitrophenyl-beta-d-lactoside
5. 4-nitrophenyl Beta-d-lactopyranoside
6. (2s,3r,4s,5r,6r)-2-[(2r,3s,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-(4-nitrophenoxy)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol
7. 4-nitrophenyl B-d-lactopyranoside
8. 4-nitrophenyl Beta-d-lactoside
9. P-nitrophenyl Beta-lactoside
10. Schembl7958085
11. Chebi:90260
12. Dtxsid001310117
13. Mfcd00069843
14. Zinc44021709
15. 4-nitrophenyl Beta -d-lactopyranoside
16. Akos030242106
17. S12130
18. P-nitrophenyl-beta-d-lactopyranoside
19. 4-nitrophenyl
20. A-d-lactopyranoside, 98%
21. Beta-d-gal-(1->4)-beta-d-glc-o-pnp
22. Beta-d-galp-(1->4)-beta-d-glcp-o-pnp
23. Q27162436
24. 4-nitrophenyl Beta-d-galactosyl-(1->4)-beta-d-glucoside
25. 4-nitrophenyl 4-o-(b-d-galactopyranosyl)-b-d-glucopyranoside
26. 4-nitrophenyl 4-o-beta-d-galactopyranosyl-beta-d-glucopyranoside
27. 4-nitrophenyl Beta-d-galactopyranosyl-(1->4)-beta-d-glucopyranoside
28. (2s,3r,4s,5r,6r)-2-((2r,3s,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-(4-nitrophenoxy)tetrahydro-2h-pyran-3-yloxy)-6-(hydroxymethyl)tetrahydro-2h-pyran-3,4,5-triol
| Molecular Weight | 463.4 g/mol |
|---|---|
| Molecular Formula | C18H25NO13 |
| XLogP3 | -2.6 |
| Hydrogen Bond Donor Count | 7 |
| Hydrogen Bond Acceptor Count | 13 |
| Rotatable Bond Count | 6 |
| Exact Mass | 463.13258985 g/mol |
| Monoisotopic Mass | 463.13258985 g/mol |
| Topological Polar Surface Area | 224 Ų |
| Heavy Atom Count | 32 |
| Formal Charge | 0 |
| Complexity | 612 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 10 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
15
PharmaCompass offers a list of 4-Nitrophenyl Beta-D-Lactopyranoside API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right 4-Nitrophenyl Beta-D-Lactopyranoside manufacturer or 4-Nitrophenyl Beta-D-Lactopyranoside supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred 4-Nitrophenyl Beta-D-Lactopyranoside manufacturer or 4-Nitrophenyl Beta-D-Lactopyranoside supplier.
PharmaCompass also assists you with knowing the 4-Nitrophenyl Beta-D-Lactopyranoside API Price utilized in the formulation of products. 4-Nitrophenyl Beta-D-Lactopyranoside API Price is not always fixed or binding as the 4-Nitrophenyl Beta-D-Lactopyranoside Price is obtained through a variety of data sources. The 4-Nitrophenyl Beta-D-Lactopyranoside Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A O-PNPL-100 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of O-PNPL-100, including repackagers and relabelers. The FDA regulates O-PNPL-100 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. O-PNPL-100 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A O-PNPL-100 supplier is an individual or a company that provides O-PNPL-100 active pharmaceutical ingredient (API) or O-PNPL-100 finished formulations upon request. The O-PNPL-100 suppliers may include O-PNPL-100 API manufacturers, exporters, distributors and traders.
O-PNPL-100 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of O-PNPL-100 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right O-PNPL-100 GMP manufacturer or O-PNPL-100 GMP API supplier for your needs.
A O-PNPL-100 CoA (Certificate of Analysis) is a formal document that attests to O-PNPL-100's compliance with O-PNPL-100 specifications and serves as a tool for batch-level quality control.
O-PNPL-100 CoA mostly includes findings from lab analyses of a specific batch. For each O-PNPL-100 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
O-PNPL-100 may be tested according to a variety of international standards, such as European Pharmacopoeia (O-PNPL-100 EP), O-PNPL-100 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (O-PNPL-100 USP).
